SCHEMBL6002270

SCHEMBL6002270

[O]C(=O)N(c1ccccc1)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.38
NR1H3 Q13133 4/20 0.36
CES1 P23141 2/20 0.35
MLYCD O95822 3/20 0.33
NR1H2 P55055 2/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
POLQ O75417 1/20 0.33
TACR1 P25103 1/20 0.33
ALDH1A1 P00352 2/20 0.32
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
GLA P06280 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002629 0.70 NPSR1 (0.34) NPSR1NR1H3CES1MLYCDNR1H2
SCHEMBL1008397 0.70 NPSR1 (0.44) NPSR1NR1H3CES1MLYCDKMT2A
SCHEMBL3938034 0.68 NPSR1 (0.43) NPSR1NR1H3CES1MLYCDNR1H2
SCHEMBL6002979 0.68 ELANE (0.32) NPSR1NR1H3NR1H2KMT2AMEN1
SCHEMBL11370851 0.67 NPSR1 (0.41) NPSR1NR1H3CES1MLYCDKMT2A
SCHEMBL28247945 0.67 NPSR1 (0.41) NPSR1NR1H3CES1MLYCDKMT2A
SCHEMBL7827701 0.67 NPSR1 (0.41) NPSR1NR1H3CES1MLYCDKMT2A
SCHEMBL1067570 0.67 NPSR1 (0.41) NPSR1NR1H3CES1MLYCDKMT2A
SCHEMBL9770531 0.66 NR1H3 (0.49) NPSR1NR1H3MLYCDNR1H2KMT2A
SCHEMBL530567 0.65 MLYCD (0.49) NPSR1NR1H3CES1MLYCDNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed